Register entry
Nanjing Delova Biotech Co., Ltd.
Data as of · How to read this entry
- Registered sites
- 0
- Active NDC listings
- 1
- Live patents
- 1
- Countries
- 0
Exclusivity
Patents and exclusivities
1| Patent | Product | Covers | Expiry |
|---|---|---|---|
| 12059423 | QAMZOVAmeloxicam | substance, product | Jul 2040 |
Catalogue
Marketed products
1| Brand | Generic name | Form / route | NDC |
|---|---|---|---|
| QAMZOVA | Meloxicam | injection, intravenous | 82972-001NDA |
Compare
Other companies listing meloxicam
- Lupin Limited14 sites · 506 NDC
- Zydus Lifesciences Limited12 sites · 717 NDC
- CIPLA PHARMACEUTICALS LIMITED7 sites · 368 NDC
- Ipca Laboratories Limited7 sites · 77 NDC
- Aurobindo Pharma Limited6 sites · 1,453 NDC
- Spectrum Pharmaceuticals, Inc.6 sites · 240 NDC
- Pharma Packaging Solutions, LLC dba Tjoapack, LLC5 sites · 667 NDC
- Unichem Laboratories Limited, India5 sites · 272 NDC
- Arch Pharmalabs Limited3 sites · 12 NDC
- Apex Healthcare Limited3 sites · 11 NDC
Enquiry
Common questions
- Is Nanjing Delova Biotech Co., Ltd. FDA approved?
- Nanjing Delova Biotech Co., Ltd. holds no registered establishment of its own; 1 drug product is listed under its name in the National Drug Code Directory, made at sites registered to other firms.
- What drugs does Nanjing Delova Biotech Co., Ltd. make?
- 1 product is listed under Nanjing Delova Biotech Co., Ltd. in the openFDA NDC Directory, most often as injection. The full breakdown by dosage form and route is above. A listing count is not a sales figure.
Compiled from FDA establishment registrations, the openFDA NDC Directory, the Orange Book and the FDA drug shortage database. Not claimed by the company. Sources and methodology.